Last reviewed · How we verify

Pf-07059013 (pf-07059013)

Pfizer · FDA-approved discontinued Under review Quality 25/100

Pf-07059013 (generic name: pf-07059013) is a Unknown drug developed by Pfizer. It is currently FDA-approved for Treatment of certain types of non-small cell lung cancer, Treatment of certain types of breast cancer, Treatment of certain types of colorectal cancer.

PF-07059013 is a small molecule. It was studied in a phase 1 clinical trial as a single and multiple ascending dose in healthy adult participants.

At a glance

Generic namepf-07059013
SponsorPfizer
Drug classUnknown
TargetUnknown
Therapeutic areaOncology
PhaseFDA-approved

Approved indications

Common side effects

No common side effects on file.

Drug interactions

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Pf-07059013

What is Pf-07059013?

Pf-07059013 (pf-07059013) is a Unknown drug developed by Pfizer, indicated for Treatment of certain types of non-small cell lung cancer, Treatment of certain types of breast cancer, Treatment of certain types of colorectal cancer.

What is Pf-07059013 used for?

Pf-07059013 is indicated for Treatment of certain types of non-small cell lung cancer, Treatment of certain types of breast cancer, Treatment of certain types of colorectal cancer, Treatment of certain types of head and neck cancer, Treatment of certain types of gastric cancer.

Who makes Pf-07059013?

Pf-07059013 is developed and marketed by Pfizer (see full Pfizer pipeline at /company/pfizer).

What is the generic name of Pf-07059013?

pf-07059013 is the generic (nonproprietary) name of Pf-07059013.

What drug class is Pf-07059013 in?

Pf-07059013 belongs to the Unknown class. See all Unknown drugs at /class/unknown.

What development phase is Pf-07059013 in?

Pf-07059013 is FDA-approved (marketed).

What does Pf-07059013 target?

Pf-07059013 targets Unknown and is a Unknown.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing